DR. PIERCING AFTERCARE- benzalkonium chloride swab

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Achète-le

Ingrédients actifs:

Benzalkonium Chloride 0.11%

Disponible depuis:

Broadway Products LLC

Mode d'administration:

TOPICAL

Type d'ordonnance:

OTC DRUG

indications thérapeutiques:

Antiseptic FDA Registered antiseptic for the care and cleaning of piercings.

Statut de autorisation:

OTC monograph not final

Résumé des caractéristiques du produit

                                DR. PIERCING AFTERCARE- BENZALKONIUM CHLORIDE SWAB
BROADWAY PRODUCTS LLC
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may_
_be marketed if they comply with applicable regulations and policies.
FDA has not_
_evaluated whether this product complies._
----------
BROADWAY PRODUCTS (AS PLD) - DR. PIERCING - AFTERCARE SWAB (81926-001)
ACTIVE INGREDIENTS
Benzalkonium Chloride 0.11%
PURPOSE
Antiseptic
USE
FDA Registered antiseptic for the care and cleaning of piercings.
WARNINGS:
FOR EXTERNAL USE ONLY.If redness, irritation, infection or swelling
occurs, discontinue
use and consult a physician. Keep out of eyes. Do not insert into the
ear canal. Store at
room temprature.
Keep out of reach of children.
DIRECTIONS:
1. Hold swab with the colored round marker end up.
2. Bend the colored round marker tip until it "snaps".
3. Liquid flows down into the white tip.
4. Apply medicated tip to piercing. Dispose.
OTHER INGREDIENTS
Isotonic Saline Solution, Aloe Vera, Allantoin, Panthenol/Pro-Vitamin
B5.
DR. PIERCING AFTERCARE
benzalkonium chloride swab
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:81926-001
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM -
UNII:7N6JUD5X6Y)
BENZ ALKONIUM
CHLORIDE
1.1 mg
in 1 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
Broadway Products LLC
METHYLCHLOROISOTHIAZOLINONE (UNII: DEL7T5QRPN)
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)
PANTHENOL (UNII: WV9CM0O67Z)
METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA)
MAGNESIUM NITRATE (UNII: 77CBG3UN78)
CUPRIC NITRATE (UNII: 9TC879S2ZV)
WATER (UNII: 059QF0KO0R)
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
TROLAMINE (UNII: 9O3K93S3TK)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
ALLANTOIN (UNII: 344S277G0Z)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
PACKAGING
# ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:81926-
001-36
36 in 1 CASE
01/01/2021
1
0.15 mL in 1 APPLICATOR; Type 0: Not a
Combinatio
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit